Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors.

Tumor endothelial marker 1 (Tem1; endosialin) is the prototypical member of a family of genes expressed in the stroma of tumors. To assess the functional role of Tem1, we disrupted the Tem1 gene in mice by targeted homologous recombination. Tem1(-/-) mice were healthy, their wound healing was normal, and tumors grew normally when implanted in s.c. sites. However, there was a striking reduction in tumor growth, invasiveness, and metastasis after transplantation of tumors to abdominal sites in mice without functional Tem1 genes. These data indicate that the stroma can control tumor aggressiveness and that this control varies with anatomic site. Therefore, they have significant implications for the mechanisms underlying tumor invasiveness and for models that evaluate this process.

[1]  E Ruoslahti,et al.  Vascular homing peptides with cell-penetrating properties. , 2005, Current pharmaceutical design.

[2]  Jayanta Debnath,et al.  Modelling glandular epithelial cancers in three-dimensional cultures , 2005, Nature Reviews Cancer.

[3]  G. Invernici,et al.  Human microvascular endothelial cells from different fetal organs demonstrate organ-specific CAM expression. , 2005, Experimental cell research.

[4]  A. Iavarone,et al.  Id family of helix-loop-helix proteins in cancer , 2005, Nature Reviews Cancer.

[5]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[6]  C. Isacke,et al.  Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium , 2005, FEBS letters.

[7]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[8]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[9]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[10]  Yan Li,et al.  Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy , 2004, Nature.

[11]  Raghu Kalluri,et al.  Cancer without disease , 2004, Nature.

[12]  B. St. Croix,et al.  Tumor endothelial markers: new targets for cancer therapy , 2004, Current opinion in oncology.

[13]  Hong Zhang,et al.  Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. , 2003, Cancer cell.

[14]  G. Frantz,et al.  Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. , 2003, Endocrinology.

[15]  D. Melton,et al.  Endothelial signaling during development , 2003, Nature Medicine.

[16]  M. Shekhar,et al.  Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast , 2003, Breast Cancer Research.

[17]  K. Kinzler,et al.  Cell surface tumor endothelial markers are conserved in mice and humans. , 2001, Cancer research.

[18]  F. Peale,et al.  Identification of an angiogenic mitogen selective for endocrine gland endothelium , 2001, Nature.

[19]  F. Eisenhaber,et al.  Molecular Cloning and Characterization of Endosialin, a C-type Lectin-like Cell Surface Receptor of Tumor Endothelium* , 2001, The Journal of Biological Chemistry.

[20]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[21]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[22]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[23]  R. Kerbel.  Tumor angiogenesis: past, present and the near future. , 2000, Carcinogenesis.

[24]  Harold E. Dvorak,et al.  Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors , 1997, Thrombosis and Haemostasis.

[25]  J. Healey,et al.  Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Gelber,et al.  H‐2Db gene transfer into highly metastatic D122 cells results in tumor rejection in allogeneic recipients, but does not affect metastasis in syngeneic recipients. Implications for mechanisms of allorejection , 1992, International journal of cancer.

[27]  R. Ocadiz,et al.  Immunologic and genetic characterization of S180, a cell line of murine origin capable of growing in different inbred strains of mice. , 1992, Veterinary immunology and immunopathology.

[28]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[29]  M J Bissell,et al.  Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression : The Role of Extracellular Matrix and Its Degrading Enzymes , 2022 .

[30]  R. Mansel,et al.  Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer , 2004, Clinical & Experimental Metastasis.